Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Riley

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Nature Clinical Practice. Rheumatology|February 1, 2008
Tendinopathy--from basic science to treatmentGraham Riley
Expert Reviews in Molecular Medicine|March 31, 2005
Chronic tendon pathology: molecular basis and therapeutic implicationsGraham Riley
International Journal of Experimental Pathology|July 11, 2013
The scientific study of tendonGraham Riley
International Journal of Experimental Pathology|August 19, 2007
Symposium: tendon and ligament remodelling and regenerationGraham Riley
Bioconjugate Chemistry|February 8, 2019
Synthesis and Fabrication of Surface-Active Microparticles Using a Membrane Emulsion Technique and Conjugation of Model Protein via Strain-Promoted Azide-Alkyne Click Chemistry in Physiological ConditionsGrace Walden, Xin Liao, Graham Riley, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2002
Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonistsSteven M Bromidge, Stephen E Clarke, Frank D King, et al.
CNS & Neurological Disorders Drug Targets|August 22, 2006
Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockadeMartyn D Wood, Claire Scott, Kirsten Clarke, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2006
Diaryl substituted pyrrolidinones and pyrrolones as 5-HT2C inhibitors: synthesis and biological evaluationFabrizio Micheli, Alessandra Pasquarello, Giovanna Tedesco, et al.
Pharmacology, Biochemistry, and Behavior|March 13, 2002
Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT(6) receptor antagonistTania O Stean, Warren D Hirst, David R Thomas, et al.
Acta Biomaterialia|August 31, 2015
Substrate topography: A valuable in vitro tool, but a clinical red herring for in vivo tenogenesisAndrew English, Ayesha Azeem, Kyriakos Spanoudes, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Nature Clinical Practice. Rheumatology|February 1, 2008
Tendinopathy--from basic science to treatmentGraham Riley
Expert Reviews in Molecular Medicine|March 31, 2005
Chronic tendon pathology: molecular basis and therapeutic implicationsGraham Riley
International Journal of Experimental Pathology|July 11, 2013
The scientific study of tendonGraham Riley
International Journal of Experimental Pathology|August 19, 2007
Symposium: tendon and ligament remodelling and regenerationGraham Riley
Bioconjugate Chemistry|February 8, 2019
Synthesis and Fabrication of Surface-Active Microparticles Using a Membrane Emulsion Technique and Conjugation of Model Protein via Strain-Promoted Azide-Alkyne Click Chemistry in Physiological ConditionsGrace Walden, Xin Liao, Graham Riley, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2002
Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonistsSteven M Bromidge, Stephen E Clarke, Frank D King, et al.
CNS & Neurological Disorders Drug Targets|August 22, 2006
Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockadeMartyn D Wood, Claire Scott, Kirsten Clarke, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2006
Diaryl substituted pyrrolidinones and pyrrolones as 5-HT2C inhibitors: synthesis and biological evaluationFabrizio Micheli, Alessandra Pasquarello, Giovanna Tedesco, et al.
Pharmacology, Biochemistry, and Behavior|March 13, 2002
Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT(6) receptor antagonistTania O Stean, Warren D Hirst, David R Thomas, et al.
Acta Biomaterialia|August 31, 2015
Substrate topography: A valuable in vitro tool, but a clinical red herring for in vivo tenogenesisAndrew English, Ayesha Azeem, Kyriakos Spanoudes, et al.
Pageof 2